Selpercatinib -New research presented at the annual meeting of the American Society of Clinical Oncology has highlighted the significant benefits of selpercatinib for patients with….
Thyroid diseases, including hypothyroidism, hyperthyroidism, and autoimmune thyroid disorders, affect millions of individuals globally.
The U.S. Food and Drug Administration (FDA) has officially approved Tremfya (guselkumab) for the treatment of adults suffering from…
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord.
